Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, ... Science 359 (6371), 97-103, 2018 | 3942 | 2018 |
Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis T Tsujikawa, S Kumar, RN Borkar, V Azimi, G Thibault, YH Chang, ... Cell reports 19 (1), 203-217, 2017 | 525 | 2017 |
Bruton tyrosine kinase–dependent immune cell cross-talk drives pancreas cancer AJ Gunderson, MM Kaneda, T Tsujikawa, AV Nguyen, NI Affara, B Ruffell, ... Cancer discovery 6 (3), 270-285, 2016 | 458 | 2016 |
IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin RS Lane, J Femel, AP Breazeale, CP Loo, G Thibault, A Kaempf, M Mori, ... Journal of Experimental Medicine 215 (12), 3057-3074, 2018 | 143 | 2018 |
Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma T Tsujikawa, T Yaguchi, G Ohmura, S Ohta, A Kobayashi, N Kawamura, ... International journal of cancer 132 (12), 2755-2766, 2013 | 138 | 2013 |
Evaluation of cyclophosphamide/GVAX pancreas followed by listeria-mesothelin (CRS-207) with or without nivolumab in patients with pancreatic cancer T Tsujikawa, T Crocenzi, JN Durham, EA Sugar, AA Wu, B Onners, ... Clinical Cancer Research 26 (14), 3578-3588, 2020 | 94 | 2020 |
Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural … R Hassan, E Alley, H Kindler, S Antonia, T Jahan, S Honarmand, N Nair, ... Clinical Cancer Research 25 (19), 5787-5798, 2019 | 88 | 2019 |
Poor response to neoadjuvant chemotherapy correlates with mast cell infiltration in inflammatory breast cancer SM Reddy, A Reuben, S Barua, H Jiang, S Zhang, L Wang, ... Cancer immunology research 7 (6), 1025-1035, 2019 | 85 | 2019 |
Dissecting the stromal signaling and regulation of myeloid cells and memory effector T cells in pancreatic cancer AB Blair, VM Kim, ST Muth, MT Saung, N Lokker, B Blouw, TD Armstrong, ... Clinical Cancer Research 25 (17), 5351-5363, 2019 | 69 | 2019 |
High-dimensional multiplexed immunohistochemical characterization of immune contexture in human cancers G Banik, CB Betts, SM Liudahl, S Sivagnanam, R Kawashima, T Cotechini, ... Methods in enzymology 635, 1-20, 2020 | 65 | 2020 |
Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer ND Pennock, HA Martinson, Q Guo, CB Betts, S Jindal, T Tsujikawa, ... Journal for immunotherapy of cancer 6, 1-23, 2018 | 56 | 2018 |
Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer MT Saung, S Muth, D Ding, DL Thomas, AB Blair, T Tsujikawa, ... Journal for immunotherapy of cancer 6, 1-11, 2018 | 55 | 2018 |
Aberrant myosin 1b expression promotes cell migration and lymph node metastasis of HNSCC G Ohmura, T Tsujikawa, T Yaguchi, N Kawamura, S Mikami, J Sugiyama, ... Molecular Cancer Research 13 (4), 721-731, 2015 | 54 | 2015 |
Exposure to particulate matter upregulates ACE2 and TMPRSS2 expression in the murine lung T Sagawa, T Tsujikawa, A Honda, N Miyasaka, M Tanaka, T Kida, ... Environmental Research 195, 110722, 2021 | 53 | 2021 |
Improvement of cancer immunotherapy by combining molecular targeted therapy Y Kawakami, T Yaguchi, H Sumimoto, C Kudo-Saito, T Iwata-Kajihara, ... Frontiers in oncology 3, 136, 2013 | 39 | 2013 |
Prognostic significance of spatial immune profiles in human solid cancers T Tsujikawa, J Mitsuda, H Ogi, A Miyagawa‐Hayashino, E Konishi, K Itoh, ... Cancer Science 111 (10), 3426-3434, 2020 | 38 | 2020 |
Using an in-house approach to computer-assisted design and computer-aided manufacturing reconstruction of the maxilla T Numajiri, D Morita, H Nakamura, S Tsujiko, R Yamochi, Y Sowa, ... Journal of Oral and Maxillofacial Surgery 76 (6), 1361-1369, 2018 | 30 | 2018 |
Cancer‐induced immunosuppressive cascades and their reversal by molecular‐targeted therapy Y Kawakami, T Yaguchi, H Sumimoto, C Kudo‐Saito, N Tsukamoto, ... Annals of the New York Academy of Sciences 1284 (1), 80-86, 2013 | 25 | 2013 |
Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status C Means, DR Clayburgh, L Maloney, D Sauer, MH Taylor, ML Shindo, ... Head & neck 41 (8), 2636-2646, 2019 | 24 | 2019 |
Use of systemic low-dose unfractionated heparin in microvascular head and neck reconstruction: influence in free-flap outcomes T Numajiri, Y Sowa, K Nishino, A Arai, T Tsujikawa, K Ikebuchi, H Nakano, ... Journal of Plastic Surgery and Hand Surgery 50 (3), 135-141, 2016 | 24 | 2016 |